Liangfang Zhang

This inventor holds 29 USPTO granted patents and 12 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Nanoparticle Technology. Top assignees: University of California, Massachusetts Institute of Technology, The Brigham and Women's Hospital, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liangfang Zhang. Retrieved from https://idiyas.com/inventor/liangfang-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 12)

% Patents Active = 93.1

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 112(Granted Patents)

Company Filing History:

20 out of 16,025

University of California

patents

9 out of 8,586

Massachusetts Institute of Technology

patents

9 out of 1,428

The Brigham and Women's Hospital, Inc.

patents

4. 5 out of 1,073

Children's Medical Center Corporation

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Nanoparticle

Drug Delivery

Vaccine Nanotechnology

Micromotors

Gastrointestinal Treatment

Detoxification

Vascular Diseases

Genomic Detection

Auto-reactive Immune Factors

Respiratory Viral Infection

Toxin-absorbing Hydrogel

Targeted Delivery

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12746212 - Treating vasculature related diseases or disorders using nanoparticles (2026-09-29),

2. 12678514 - Algae-based microrobot for drug delivery (2026-07-14),

3. 12522874 - Broad-spectrum nanoparticle enabled genomic detection (2026-01-13),

4. 12285472 - Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses thereof (2025-04-29),

5. 12097290 - Membrane encapsulated nanoparticles and method of use (2024-09-24),

6. 12083162 - Universal nanosponge for treating respiratory viral infection (2024-09-10),

7. 12016948 - Micromotors and nanomotors for gastrointestinal diagnosis and treatment applications (2024-06-25),

8. 11547667 - Vaccine nanotechnology (2023-01-10),

9. 11357736 - Detoxification using nanoparticles (2022-06-14),

10. 11241394 - Treating vasculature related diseases or disorders using nanoparticles (2022-02-08),

11. 11224577 - Treating infection by a platelet-targeting microbe using nanoparticles (2022-01-18),

12. 11007281 - Nano/micromotors for active and dynamic intracellular payload delivery (2021-05-18),

13. 11007147 - Hydrogel toxin-absorbing or binding nanoparticles (2021-05-18),

14. 11000593 - Cellular or viral membrane coated nanostructures and uses thereof (2021-05-11),

15. 10736848 - Vaccine nanotechnology (2020-08-11),

Title: The Innovative Mind of Liangfang Zhang

Introduction: Liangfang Zhang is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to the field of nanotechnology and biomedical engineering.

Latest Patents: Liangfang Zhang holds several patents in the areas of drug delivery systems, nanomedicine, and biomaterials, showcasing his commitment to advancing healthcare through innovative technologies.

Career Highlights: With a distinguished career spanning over two decades, Liangfang Zhang has made significant strides in developing nanoscale materials for targeted drug delivery, leading to more effective and personalized treatment options for patients.

Collaborations: Throughout his career, Liangfang Zhang has collaborated with leading researchers, pharmaceutical companies, and medical institutions to translate his inventions from the lab to real-world applications, further solidifying his impact on the field.

Conclusion: Liangfang Zhang's relentless pursuit of innovation and his passion for improving healthcare have established him as a key figure in the world of nanotechnology and biomedical engineering, with his work continuing to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.